Damora Therapeutics (DMRA) Preferred Shares (2025 - 2026)
Damora Therapeutics (DMRA) posted Preferred Shares of $13.5 million for Q1 2026, down 95.46% on a QoQ basis from $297.3 million in Q4 2025.
Damora Therapeutics (DMRA) Preferred Shares (2025 - 2026) Analysis & Trends
Damora Therapeutics' Preferred Shares history runs 2 years deep, the most recent figure standing at $13.5 million for Q1 2026.
- Quarterly Preferred Shares changed N/A year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (changed N/A YoY) and the FY2025 annual result came in at $297.3 million, changed N/A from the prior year.
- Preferred Shares was $13.5 million for Q1 2026 at Damora Therapeutics, down from $297.3 million in the prior quarter.
- Across five years, Preferred Shares topped out at $297.3 million in Q4 2025 and bottomed at $13.5 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | 13.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.49 Mn |
| Dec 31, 2025 | 297.29 Mn |